0001127602-21-019395.txt : 20210607 0001127602-21-019395.hdr.sgml : 20210607 20210607182343 ACCESSION NUMBER: 0001127602-21-019395 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210604 FILED AS OF DATE: 20210607 DATE AS OF CHANGE: 20210607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knell Michael Gunnar CENTRAL INDEX KEY: 0001543779 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 211000730 MAIL ADDRESS: STREET 1: BRUKER CORPORATION STREET 2: 40 MANNING ROAD CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1226 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC DATE OF NAME CHANGE: 20000605 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-06-04 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL 0001543779 Knell Michael Gunnar 251 BALLARDVALE STREET WILMINGTON MA 01887 1 CSVP&Chief Accounting Officer Common Stock 2021-06-04 4 M 0 388 109.34 A 4618 D Common Stock 2021-06-04 4 M 0 735 144.67 A 5353 D Common Stock 2021-06-04 4 M 0 404 179.66 A 5757 D Common Stock 2021-06-04 4 S 0 1527 335.2364 D 4230 D Stock Options (Right to Buy) 109.34 2021-06-04 4 M 0 388 0 D 2019-02-23 2023-02-23 Common Stock 388 855 D Stock Options (Right to Buy) 144.67 2021-06-04 4 M 0 735 0 D 2020-02-22 2024-02-22 Common Stock 735 1471 D Stock Options (Right to Buy) 179.66 2021-06-04 4 M 0 404 0 D 2021-05-29 2030-05-29 Common Stock 404 1212 D This transaction was executed in multiple trades at prices ranging from $335.17 to $335.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Michael G. Knell 2021-06-07